Decoding the Plasma Proteomic Landscape of Clear Cell Renal Cell Carcinoma Reveals Diagnostic and Prognostic Liquid Biopsy Biomarkers
Lakshminarayanan, H.; Rutishauser, D.; Schraml, P.; Eberli, D.; Bolck, H.; Moch, H.
Show abstract
Clear cell renal cell carcinoma (ccRCC) remains the most lethal urological malignancy, with high metastatic rates, both at initial diagnosis and during disease progression, contributing to poor survival outcomes. Current diagnostic and prognostic approaches rely primarily on histopathology, limiting early detection of localized disease and relevant intervention for metastatic patients. Here, we performed the most extensive to-date mass spectrometry-based discovery profiling of longitudinal plasma samples collected across multiple clinical follow-up points spanning up to five years post-diagnosis., to characterize the circulating plasma proteome and identify biomarkers for localized and metastatic disease. Network analysis identified protein modules enriched in pathways involved in matrix remodeling and metabolic deregulation, perpetuating the ccRCC phenotype. A five-protein signature, comprising PRL, THBS1, ANGPT1, IGFBP1, and SRGN, demonstrated high diagnostic performance for localized ccRCC. Notably, PRL appeared as a promising stand-alone biomarker (AUC = 0.812), with independent validation confirming its utility as a diagnostic biomarker. Importantly, a six-protein signature (AMBP, C1S, C2, IGFBP3, RASGRP2, TFRC) stringently distinguished metastatic from high-grade non-metastatic ccRCC cases. Further validation of these signatures could inform clinical decision-making, enabling early detection of metastasis and minimal residual disease and real-time longitudinal monitoring for ccRCC patients. Statement of SignificanceThis study presents the most comprehensive longitudinal plasma proteomic dataset for ccRCC to date, defining robust circulating protein biomarker signatures for both localized and metastatic disease, and establishing a proteomic landscape for minimally invasive, real-time monitoring and improved clinical management of ccRCC patients. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=118 SRC="FIGDIR/small/742031v1_ufig1.gif" ALT="Figure 1000"> View larger version (35K): org.highwire.dtl.DTLVardef@16a0a0aorg.highwire.dtl.DTLVardef@b950b1org.highwire.dtl.DTLVardef@60ca2dorg.highwire.dtl.DTLVardef@7980c3_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 15 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Multi-omics Biomarker Pipeline Reveals Elevated Levels Of Protein-Glutamine Gamma-Glutamyltransferase 4 In Seminal Plasma Of Patients With Prostate Cancer 92%
- Glycoinformatic profiling of label-free intact heparan sulfate oligosaccharides 90%
- A549 tumorigenic and BEAS-2B non-tumorigenic cell line derived small extracellular vesicles show distinct proteomic, N-glycoproteomic and chondroitin/dermatan sulfate profiles 89%
Similar papers in this journal
- Proteomic Characterization of Acute Kidney Injury in Patients Hospitalized with SARS-CoV2 Infection 91%
- Minimal Correlation but Complementary Diagnostic Utility for Plasma Cell-free RNA and Proteins 91%
- Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancer 91%
Similar papers in this journal
Similar papers in this journal
- Prohibitin is a prognostic marker of relapse and therapeutic target to block chemotherapy resistance in Wilms tumor 94%
- Integration of urine proteomics and renal single-cell genomics identifies an interferon-gamma response gradient in lupus nephritis. 92%
- Therapeutic splice modulation of COL4A5 reinstates collagen IV assembly in an organoid model of X-linked Alport syndrome 90%
Similar papers in this journal
- Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts 92%
- Identification of endogenous Adenomatous polyposis coli interaction partners and β-catenin-independent targets by proteomics 88%
- Human Prostate Cancer-Associated Macrophage Subtypes with Prognostic Potential Revealed by Single-cell Transcriptomics 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.